Free Trial

GT Biopharma (GTBP) Institutional Ownership

GT Biopharma logo
$2.94
-0.07 (-2.33%)
(As of 10/31/2024 ET)

Institutional Ownership Changes (13F Filings) for GT Biopharma (NASDAQ:GTBP)

Current
Institutional Ownership
Percentage
8.15%
Number of
Institutional Buyers
(last 12 months)
1
Total
Institutional Inflows
(last 12 months)
$4.84M
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$326.26K
Get GTBP Insider Trade Alerts

Want to know when executives and insiders are buying or selling GT Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

GTBP Institutional Buying and Selling by Quarter

GT Biopharma Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/8/2024 DekaBank Deutsche Girozentrale978,358$2.77M0.0%-10.5%69.044%
6/4/2024 DekaBank Deutsche Girozentrale1,093,645$47.45M0.1%N/A77.017%
8/2/2023Bank of Montreal Can596,240$262K0.0%N/A1.596%
1/23/2023 Baskin Financial Services Inc.151,354$134K0.0%N/A0.466%
11/7/2022Virtu Financial LLC24,864$44K0.0%N/A0.076%
5/5/2022Russell Investments Group Ltd.11,007$31K0.0%N/A0.033%
5/2/2022 Allspring Global Investments Holdings LLC25,782$74K0.0%N/A0.078%
4/20/2022Sigma Planning Corp21,400$62K0.0%N/A0.067%
2/14/2022Gordian Capital Singapore Pte Ltd35,000$107K0.1%N/A0.114%
2/9/2022 Compagnie Lombard Odier SCmA30,000$92K0.0%+100.0%0.098%
2/4/2022Crumly & Associates Inc.32,163$85K0.0%N/A0.105%
2/3/2022 Brighton Jones LLC11,288$34K0.0%N/A0.037%
1/31/2022Commonwealth Equity Services LLC11,052$33K0.0%N/A0.036%
11/16/2021Two Sigma Advisers LP51,100$344K0.0%+243.0%0.242%
11/16/2021Two Sigma Investments LP162,823$1.10M0.0%N/A0.771%
11/15/2021Marshall Wace LLP16,577$112K0.0%-35.7%0.078%
11/15/2021Franklin Resources Inc.28,500$192K0.0%N/A0.135%
11/12/2021Renaissance Technologies LLC84,700$571K0.0%N/A0.401%
11/12/2021Geode Capital Management LLC424,279$2.86M0.0%+22.4%2.008%
11/10/2021Goldman Sachs Group Inc.52,426$353K0.0%N/A0.248%
11/9/2021BlackRock Inc.1,155,228$7.79M0.0%-18.3%5.468%
11/8/2021State Board of Administration of Florida Retirement System18,224$123K0.0%N/A0.086%
11/8/2021Russell Investments Group Ltd.9,642$64K0.0%N/A0.046%
11/5/2021 Welch Group LLC10,000$67K0.0%N/A0.047%
11/4/2021Deutsche Bank AG11,400$77K0.0%-25.7%0.054%
11/2/2021 New York State Common Retirement Fund8,230$55K0.0%-59.7%0.039%
8/25/2021Marshall Wace LLP25,792$400K0.0%N/A0.122%
8/17/2021Metropolitan Life Insurance Co NY8,782$136K0.0%N/A0.042%
8/17/2021MetLife Investment Management LLC11,471$178K0.0%N/A0.054%
8/17/2021Citadel Advisors LLC510,058$7.91M0.0%N/A2.414%
8/16/2021California State Teachers Retirement System32,878$510K0.0%N/A0.156%
8/16/2021Charles Schwab Investment Management Inc.57,993$899K0.0%N/A0.274%
8/16/2021State Street Corp374,704$5.81M0.0%N/A1.773%
8/16/2021Nuveen Asset Management LLC82,151$1.27M0.0%N/A0.389%
8/16/2021Marshall Wace LLP25,792$400K0.0%N/A0.122%
8/13/2021Northern Trust Corp225,457$3.50M0.0%+555.6%1.067%
8/13/2021Geode Capital Management LLC346,606$5.37M0.0%+165.8%1.641%
8/13/2021Vanguard Group Inc.982,269$15.23M0.0%+267.0%4.649%
8/12/2021Legal & General Group Plc2,524$39K0.0%N/A0.012%
8/12/2021JPMorgan Chase & Co.9,155$142K0.0%N/A0.043%
The real reason Elon is fully endorsing Trump (Ad)

Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump.

Watch this new documentary and you’ll discover what Elon knows,
8/12/2021The Manufacturers Life Insurance Company13,758$213K0.0%N/A0.065%
8/11/2021Bank of New York Mellon Corp58,711$910K0.0%N/A0.278%
8/11/2021BlackRock Inc.1,413,391$21.91M0.0%N/A6.690%
8/11/2021Deutsche Bank AG15,349$237K0.0%N/A0.073%
8/10/2021Citigroup Inc.6,134$95K0.0%N/A0.029%
8/6/2021Ameritas Investment Partners Inc.1,870$29K0.0%N/A0.009%
8/5/2021Rhumbline Advisers18,634$289K0.0%N/A0.088%
8/2/2021 New York State Common Retirement Fund20,400$316K0.0%N/A0.097%
8/2/2021Advisor Group Holdings Inc.2,943$45K0.0%+108.3%0.014%
7/31/2021 Davy Global Fund Management Ltd35,113$544K0.1%+33.4%0.166%
7/15/2021 Compagnie Lombard Odier SCmA15,000$233K0.0%N/A0.071%
7/6/2021Silverleafe Capital Partners LLC104,000$1.61M0.6%N/A0.492%
5/19/2021Virtu Financial LLC22,741$156K0.0%N/A0.080%
5/19/2021Squarepoint Ops LLC16,543$113K0.0%N/A0.058%
5/18/2021Millennium Management LLC27,895$191K0.0%N/A0.098%
5/17/2021Royal Bank of Canada24,542$167K0.0%N/A0.086%
5/12/2021Northern Trust Corp34,387$235K0.0%N/A0.121%
5/12/2021Geode Capital Management LLC130,388$891K0.0%N/A0.459%
5/12/2021UBS Group AG3,918$27K0.0%N/A0.014%
5/11/2021 Davy Global Fund Management Ltd26,321$180K0.0%N/A0.093%
(Data available from 1/1/2016 forward)

GTBP Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of GTBP shares?

During the previous two years, the following institutional investors and hedge funds held shares of GT Biopharma shares: DekaBank Deutsche Girozentrale ($2.77M), Bank of Montreal Can ($262K), and Baskin Financial Services Inc. ($134K), Virtu Financial LLC ($44K).Learn more on GTBP's institutional investors.

What percentage of GT Biopharma stock is owned by institutional investors?

8.15% of GT Biopharma stock is owned by institutional investors. Learn more on GTBP's institutional investor holdings.

Which institutional investors have been buying GT Biopharma stock?

The following institutional investors have purchased GT Biopharma stock in the last 24 months: DekaBank Deutsche Girozentrale ($1.09M), Bank of Montreal Can ($596.24K), Baskin Financial Services Inc. ($151.35K), and Virtu Financial LLC ($24.86K).

How much institutional buying is happening at GT Biopharma?

Institutional investors have bought a total of 1,866,103 shares in the last 24 months. This purchase volume represents approximately $15.76M in transactions.

Which GT Biopharma major shareholders have been selling company stock?

The following institutional investors have sold GT Biopharma stock in the last 24 months: DekaBank Deutsche Girozentrale ($115.29K).

How much institutional selling is happening at GT Biopharma?

Institutional investors have sold a total of 115,287 shares in the last 24 months. This volume of shares sold represents approximately $326.26K in transactions.



This page (NASDAQ:GTBP) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners